Stockscreener 앱 받기
33.92
1.10%
0.37
시간 외 거래:
33.93
0.010
+0.03%
전일 마감가:
$33.55
열려 있는:
$33
하루 거래량:
1.93M
Relative Volume:
0.67
시가총액:
$3.92B
수익:
-
순이익/손실:
$-359.64M
주가수익비율:
-10.66
EPS:
-3.1831
순현금흐름:
$-278.69M
1주 성능:
-4.37%
1개월 성능:
+9.07%
6개월 성능:
+33.54%
1년 성능:
+12.80%
1일 변동 폭
$32.70
$34.50
1주일 범위
$32.70
$37.50
52주 변동 폭
$18.92
$43.15
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Compare VKTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
33.92 | 3.88B | 0 | -359.64M | -278.69M | -3.1831 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-29 | 개시 | Canaccord Genuity | Buy |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Goldman | Neutral |
| 2025-02-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-07 | 개시 | Citigroup | Neutral |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-11-22 | 개시 | B. Riley Securities | Buy |
| 2024-11-04 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-11 | 개시 | JP Morgan | Overweight |
| 2024-06-27 | 개시 | Morgan Stanley | Overweight |
| 2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 재확인 | Oppenheimer | Outperform |
| 2024-03-07 | 개시 | Jefferies | Buy |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2023-05-31 | 재개 | ROTH MKM | Buy |
| 2023-03-28 | 재확인 | Maxim Group | Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 개시 | BMO Capital Markets | Outperform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-05-01 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | Oppenheimer | Outperform |
| 2019-06-25 | 개시 | Stifel | Buy |
| 2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 재확인 | Maxim Group | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-18 | 재확인 | Maxim Group | Buy |
| 2018-09-18 | 재확인 | Raymond James | Outperform |
| 2018-07-20 | 개시 | SunTrust | Buy |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-01 | 재확인 | Laidlaw | Buy |
| 2018-05-31 | 재확인 | Maxim Group | Buy |
| 2018-03-26 | 재개 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | Maxim Group | Buy |
| 2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Viking Therapeutics: Phase 3 Obesity Data Feels Like A Coin Toss (Rating Downgrade) (VKTX) - Seeking Alpha
VIKING THERAPEUTICS, INC. (VKTX) - MSN
Viking Therapeutics, Inc. (VKTX) exceeds market returns: Some facts to consider - MSN
Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum? - TradingView
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market - MSN
Better weight loss drug stock buy: Eli Lilly vs Viking Therapeutics - MSN
Weight Loss Drug Market Analysis 2026: Leaders, Oral Drugs & Competitive LandscapeNews and Statistics - IndexBox
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics - Yahoo Finance
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics - The Motley Fool
Viking Therapeutics, Inc. $VKTX Shares Sold by Kintayl Capital LP - MarketBeat
Viking Therapeutics, Inc. (VKTX) Outperforms the Market: Key Points to Note - Bitget
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) suffers a larger drop than the general market: Key insights - MSN
Jim Cramer Recommends Eli Lilly Over Viking Therapeutics - MSN
3 Companies at the Forefront of the GLP-1 Pill Wars - MarketBeat
Granahan Investment Management LLC Sells 115,562 Shares of Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics, Inc. $VKTX Stock Holdings Cut by Braidwell LP - MarketBeat
Baker BROS. Advisors LP Acquires New Shares in Viking Therapeutics, Inc. $VKTX - MarketBeat
Viking Therapeutics (VKTX) Valuation Check As Obesity Drug VK2735 Advances Into Phase 3 Trials - simplywall.st
Viking Therapeutics, Inc. $VKTX Shares Acquired by Quinn Opportunity Partners LLC - MarketBeat
Is Viking Therapeutics (VKTX) one of the shorted biotech stocks to invest in? - MSN
Viking Therapeutics rises after Q4 updates on obesity therapy - MSN
Why Viking Therapeutics (VKTX) Is Up 12.6% After Fast-Tracking VK2735 Into Late-Stage Obesity TrialsAnd What's Next - simplywall.st
Why is Viking Therapeutics (VKTX) up 16.3% since last earnings report? - MSN
Why Has Viking Therapeutics (VKTX) Increased by 16.3% Since Its Previous Earnings Announcement? - Bitget
Why Is Viking Therapeutics (VKTX) Up 16.3% Since Last Earnings Report? - Yahoo Finance
VKTX Stock Extends Red-Hot Streak: Insider Scoops Up Shares As Multiple Phase 3 Trials Loom This Year In Obesity Race - Stocktwits
Viking Therapeutics Phase 3 Obesity Move Tests VK2735 Valuation Gap - Sahm
Is Viking Therapeutics (VKTX) Price Move Justified By DCF And Book Value Signals - Yahoo Finance
Jefferies Maintains Buy on Viking Therapeutics, Inc. (VKTX) March 2026 - Meyka
Jefferies reiterates Buy on Viking Therapeutic stock, $101 target - Investing.com
Can Viking Therapeutics Capitalize on Weight Loss Drugs for a Comeback? - NAI500
Net current asset value per share of Viking Therapeutics, Inc. – LS:A12GD6 - TradingView
WINTON GROUP Ltd Buys Shares of 68,700 Viking Therapeutics, Inc. $VKTX - MarketBeat
Here's Why Viking Therapeutics Stock Recovered and Can Soar in 2026 - The Motley Fool
Here's Why Viking Therapeutics Stock Recovered and Can Soar 2026 - AOL.com
Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know - MSN
How Viking Therapeutics Inc. (VKTX) Affects Rotational Strategy Timing - Stock Traders Daily
Insider Buying: Neil Aubuchon Acquires Shares of Viking Therapeu - GuruFocus
Management Purchase Signals Confidence in Viking Therapeutics' Pipeline - AD HOC NEWS
Viking Therapeutics (NASDAQ:VKTX) Insider Acquires $149,912.50 in Stock - MarketBeat
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):